SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  EQUITY ALERT: The Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important September 8, 2014 Class Action Deadline - RGDO

[August 25, 2014]

EQUITY ALERT: The Rosen Law Firm Reminds Regado Biosciences, Inc. Investors of Important September 8, 2014 Class Action Deadline - RGDO

NEW YORK --(Business Wire)--

Rosen Law Firm reminds purchasers of Regado Biosciences securities (NASDAQ:RGDO) including open market purchasers and those who purchased in Regado's IPO between August 22, 2013 and July 9, 2014 of the important September 8, 2014 lead plaintiff deadline in the class action.

To join the Regado class action, go to the website at http://rosenlegal.com/cases-305.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.


NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants made inaccurate statements of material fact or failed to disclose in its IPO documents: (1) the administration of Revolixys presented a significant risk of severe allergic reaction, which substantially undermined Revolixys' potential to become the new standard of care for anticoagulation therapy for patients undergoing cardiovascular procedures such as percutaneous coronary intervention ("PCI (News - Alert)") to open or widen obstructed coronary arteries; and (2) the Company's positive statements about Revolixys' clinical development and potential to become the standard of care for anticoagulation therapy for patients undergoing PCI and other cardiovascular procedures, were materially false and misleading or lacked a reasonable basis. The lawsuit claims that when this adverse information entered the market, the price of Regado shares dropped, damaging investors.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2014. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.